Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

High-Energy Laser in the Conservative Treatment of Rhizarthrosis

NCT: NCT07566507 · RECRUITING

NCT IDNCT07566507
StatusRECRUITING
Start Date2025-11-01
Completion2028-12-01

Brief Summary

Osteoarthritis (OA) is a degenerative joint disease that can affect the hands and is particularly debilitating when it involves the trapeziometacarpal joint (rhizarthrosis). It causes pain, deformity, limited movement and strength, joint instability, resulting in significant limitations in daily activities.Many conservative treatments, such as medications, therapeutic exercises, physical therapy, and orthoses, are effective for managing hand OA. For patients who do not respond to conservative treatments, surgical intervention will be necessary.

Frequently Asked Questions

What is High-Energy Laser in the Conservative Treatment of Rhizarthrosis?

High-Energy Laser in the Conservative Treatment of Rhizarthrosis is a clinical trial registered under NCT07566507. Current status: RECRUITING.

What is the status of NCT07566507?

The current status of NCT07566507 (High-Energy Laser in the Conservative Treatment of Rhizarthrosis) is: RECRUITING.

When did High-Energy Laser in the Conservative Treatment of Rhizarthrosis start?

High-Energy Laser in the Conservative Treatment of Rhizarthrosis started on 2025-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.